Compass Pathfinder Ltd., a subsidiary of Compass Pathways Plc, is a British company located in Altrincham. The firm engages in research and experimental development on biotechnology.

CaaMTech is the foremost drug discovery and lead optimization company focused on engineering psychedelic drugs that meet the standards of modern medicine. CaaMTech is improving the health and happiness of humankind by creating and optimizing psychedelic compounds and formulations through rigorous science and continuous innovation.

The University Hospital of Basel (German: Universitätsspital Basel, USB), in Basel, is one of the five university hospitals of Switzerland. Since 1842 it is located in a former palace, the Markgräflerhof.

Compass Pathways Plc is an investment holding company. It operates through its subsidiaries which provide mental health care services. The company was founded by Goldsmith George Jay and Malievaskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

MagicMed Industries is a privately-held biotechnology company focused on creating a library of novel derivative psychedelic molecules such as psilocybin, N,N-dimethyltryptamine (DMT) and other molecular derivatives with applications across multiple indications, in an all-stock transaction.

Part of Filament Health Corp., Psilo Scientific Ltd. is a Canadian company located in Burnaby, BC. The firm provides drug discovery services. On March 08, 2021 1287396 BC Ltd. acquired Psilo Scientific Ltd. for $0.16 million.

Diamond Therapeutics, Inc. is a Canadian company located in Toronto, ON. The firm provides psychedelic drug development services. It was founded by Judy Blumstock, she is the current CEO of the firm.\nThe company says this about itself: Diamond Therapeutics is a drug development company based in Toronto, Ontario. Our mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. Diamond is focused on sub-perceptual, non-hallucinogenic treatments that hold potential for use across a broad patient cohort —maximizing the positive impact better drugs can have on global mental health.

Lennham Pharmaceuticals, Inc. is an American private company located in Concord, MA. The firm develops pharmaceutical products. Bradford C. Sippy is currently the CEO of the company.\nThe company says this about itself: Lennham is a privately held, clinical-stage life sciences company focused on the creative application of deuterium chemistry to highly utilized and well-characterized compounds. Founded in 2019, Lennham’s unique approach to deuteration has enabled it to rapidly develop a pipeline of product candidates, including deuterium-enriched forms of psilocybin, caffeine, and an androgen-receptor agonist.

CB Therapeutics is a biotech company that specializes in the biosynthetic production of cannabinoids from sugar. CB Therapeutics produces pure cannabinoids like CBD and THC using yeast and sugar. No plants involved.

Intima Bioscience, Inc. is an American private company located in New York, NY. The firm develops therapeutic products to treat cancer. Alessandro Riva is the CEO, in this role since 2021.\nThe company says this about itself: Intima Bioscience is a company advancing checkpoint cell therapy, an approach that combines the use of patients? own immune cells with immune checkpoint targeting, in solid tumors with curative intent. Intima is currently running a Phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint CISH in patients with gastrointestinal and colon cancers.

Pike Therapeutics specializes in developing safe and effective cannabinoid formulations with superior drug delivery. It focuses on biotech, synthetic cannabinoids, and superior patch delivery. It was founded in 2019 and headquartered in Toronto, Canada.

Psilera, Inc. (doing business as Psilera) is an American company located in Tampa, FL. The firm operates as a bioscience firm. It was founded in 2019 by Chris Witowski and Jackie von Salm. Chris Witowski has been the CEO since the company founding.\nThe company says this about itself: Psilera Inc. is a psychedelic-based biotechnology company developing its proprietary neuromodulator pipeline to target mental health disorders. With a proven and award-winning executive team, Psilera leverages research strengths from the pharmaceutical and cannabis industries to repurpose psychoactive natural products into patient-centric treatments. New formulations tailoring the therapeutic effects of DMT will improve treatment scalability and patient compliance further expanding addressable markets. Psilera's technology platform (BRAIN) will identify next-generation compounds with modified psychedelic and therapeutic effects in the areas of mood, cognitive, and substance use disorders.

Teknologian Tutkimuskeskus VTT Oy provides technology solutions and innovation services. It offers its services in the sectors of bioeconomy, health and wellbeing, digital society, sustainable city, low carbon energy, technology industry, business development, and research infrastructure. The company was founded on January 16, 1942 and is headquartered in Espoo, Finland.

Part of Emergex Vaccines Holding Ltd., Emergex USA Corp. is an American company located in Doylestown, PA, that operates as a clinical-stage biotechnology company that engages in developing vaccines for immune protection.

Silo Pharma, Inc. is a developmental stage biopharmaceutical company, which engages in the merging of traditional therapeutics with psychedelic research. It seeks to acquire and develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs. The company was founded by Eric Weisblum on July 13, 2010 and is headquartered in Englewood Cliffs, NJ.

NeonMind Biosciences, Inc. focuses in drug development to evaluate the safety and efficacy of psychedelic substances for therapeutic uses as approved medicines. It operates through the Pharmaceutical, and Consumer divisions. The Pharmaceutical division deals with drug development of psychedelic compounds and a consumer products division with a focus on mushroom infused products including functional foods, natural health products, and dietary supplements. The Consumer divisions engages in the sale of four branded coffee products in Canada through NeonMind's direct to consumer e-commerce platform. The company was founded by Jeff B. Smith and Penny White in 2019 and is headquartered in Vancouver, Canada.

Part of Wesana Health Holdings, Inc., WeSana Health, Inc. is a company headquartered in Homer Glen, IL. The firm engages in development and delivery of psychedelic and naturally-sourced therapies. It was founded by Daniel Carcillo and Chad Bronstein. Daniel Carcillo is currently the CEO of the company. Debut Diamonds, Inc. acquired WeSana Health, Inc. on April 28, 2021.\nThe company says this about itself: Wesana Health is an emerging life sciences company championing the development and delivery of psychedelic and naturally-sourced therapies to treat traumatic brain injury (TBI). Through extensive clinical research and academic partnerships, Wesana Health is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological and mental health ailments caused by trauma.

Cybin IRL Ltd. is an Irish company located in North Wall Quay. The firm operates as a biopharmaceutical company. Douglas L. Drysdale is currently the CEO of the firm.

Eleusis Benefit Corp. PBC provides pharmaceuticals services. The company was founded in 2013 and is headquartered in New York, NY.